Fractionated administration of carboplatin/paclitaxel reduces neurotoxicity in patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fractionated administration of carboplatin/paclitaxel reduces neurotoxicity in patients with advanced non-small cell lung cancer

Published:2011-10 Issue:9 Volume:22 Page:926-932
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Ishii Yoshiki,Fujimoto Sakae,Okazaki Kazumi,Miyoshi Masaaki,Furihata Tomoe,Hase Isano,Takizawa Hidenori,Kikkawa Yasuko,Yamada Issei,Fukuda Takeshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference28 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.;Schiller;N Engl J Med,2002

2. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.;Johnson;J Clin Oncol,2004

3. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.;Sandler;N Engl J Med,2006

4. One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.;Hainsworth;Eur J Cancer,1998

5. Randomized trial of single agent paclitaxel given weekly versus every three weeks and with per oral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum.;Rosenberg;Acta Oncol,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impacts of race and regimens on the efficacy and safety of paclitaxel and platinum combination treatment for patients with advanced non-small cell lung cancer;European Journal of Clinical Pharmacology;2021-03-29

2. The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2017-12

3. Biweekly administration of docetaxel and carboplatin for advanced or recurrent endometrial and ovarian carcinomas;EUR J GYNAECOL ONCOL;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3